Inventor · disambiguated record
Weihe Zhang
Also filed as: ZHANG WEIHE
39 granted patents·7 pending applications·142 citations·filing 2012–2024
97Inventor score
Top patents by PatentIndex Score
46 records- 0197US11230530B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Jan 25, 2022·5 cites·22 claims
- 0297US11203574B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 21, 2021·5 cites·22 claims
- 0397US11192861B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 7, 2021·5 cites·27 claims
- 0497US10689346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 23, 2020·10 cites·38 claims
- 0597US10633345B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Apr 28, 2020·10 cites·25 claims
- 0697US10329260B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Jun 25, 2019·26 cites·45 claims
- 0797US10125102B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2015·Granted Nov 13, 2018·24 cites·16 claims
- 0896US11708333B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·23 claims
- 0996US11708332B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 1096US11685721B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 27, 2023·2 cites·33 claims
- 1195US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 1295US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 1395US10004755B2Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activityUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted Jun 26, 2018·8 cites·20 claims
- 1494US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 1593US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 1692US2025257040A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 1792US2025270171A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 1891US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 1991US11559515B2Indole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2020·Granted Jan 24, 2023·2 cites·19 claims
- 2091US9555031B2Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activityUNIV NORTH CAROLINA CHAPEL HILL·Filed 2015·Granted Jan 31, 2017·4 cites·12 claims
- 2188US12162838B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Dec 10, 2024·0 cites·28 claims
- 2288US12116346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Oct 15, 2024·0 cites·26 claims
- 2387US10849883B2Benzopyrazole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2017·Granted Dec 1, 2020·3 cites·21 claims
- 2486US11661426B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2018·Granted May 30, 2023·2 cites·42 claims
- 2586US2024294494A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 2684US9649309B2Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activityUNIV NORTH CAROLINA CHAPEL HILL·Filed 2015·Granted May 16, 2017·2 cites·10 claims
- 2783US10562850B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2016·Granted Feb 18, 2020·2 cites·23 claims
- 2880US11066360B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jul 20, 2021·1 cites·20 claims
- 2979US2024376117A1Imidazole-containing inhibitors of alk2 kinaseBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 3078US9795606B2Pyrrolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Oct 24, 2017·2 cites·20 claims
- 3178US9273056B2Pyrrolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA·Filed 2012·Granted Mar 1, 2016·3 cites·41 claims
- 3277US12054492B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2023·Granted Aug 6, 2024·0 cites·37 claims
- 3377US10759759B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2017·Granted Sep 1, 2020·1 cites·30 claims
- 3477US9562047B2Pyrazolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2013·Granted Feb 7, 2017·3 cites·9 claims
- 3576US12485109B2Pyrrolo 12.3-dipyrimidine compounds and analogues thereofBIOCRYST PHARM INC·Filed 2023·Granted Dec 2, 2025·0 cites·7 claims
- 3675US9567326B2Pyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2013·Granted Feb 14, 2017·3 cites·11 claims
- 3771US11807605B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Nov 7, 2023·0 cites·35 claims
- 3868US11618731B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Apr 4, 2023·0 cites·13 claims
- 3957US2024239752A1Bicyclic heteroaromatic inhibitors of klk5BIOCRYST PHARM INC·Filed 2022·Application pending·0 cites
- 4055US10179133B2Pyrrolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted Jan 15, 2019·0 cites·19 claims
- 4155US9744172B2Pyrazolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Aug 29, 2017·0 cites·22 claims
- 4255US2024270750A1Imidazole-containing inhibitors of alk2 kinaseBIOCRYST PHARM INC·Filed 2022·Application pending·0 cites
- 4351US2025275991A1Oral complement factor d inhibitorsBIOCRYST PHARM INC·Filed 2020·Application pending·0 cites
- 4444US9771330B2Pyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2013·Granted Sep 26, 2017·0 cites·3 claims
- 4543US12275737B2Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applicationsMERYX INC·Filed 2020·Granted Apr 15, 2025·0 cites·16 claims
- 4638US11001586B2Alkyl pyrrolopyrimidine analogs and methods of making and using sameUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted May 11, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Weihe Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →